That 91.1% benefit ratio is harsh. For context, anything above 90% offers very scant opportunities for profitability.
The healthcare giant has had trouble winning over investors in the past year despite an incredibly low valuation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results